✦ LIBER ✦

Post-stratification approach to missing data problems in clinical trials

✍ Scribed by Young Jack Lee; Jonas Ellenberg

Book ID: 113297233
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 74 KB
Volume: 12
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(91)90091-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Missing quality of life data in cancer c

Missing quality of life data in cancer clinical trials: serious problems and challenges

✍ Jürg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor

A Bayesian Approach to Surrogacy Assessm

A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials

✍ Yun Li; Jeremy M.G. Taylor; Michael R. Elliott 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

A structured framework for assessing sen

A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials

✍ Mallinckrodt, C.H.; Lin, Q.; Molenberghs, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

24P An object-based approach to data man

24P An object-based approach to data management in clinical trials

✍ Diana L. Urbauer; James W. West III 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Missing data in quality of life research

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions

✍ Elizabeth A. Hahn; Kimberly A. Webster; David Cella; Diane L. Fairclough 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement sele

Why are missing quality of life data a p

Why are missing quality of life data a problem in clinical trials of cancer therapy?

✍ Diane L. Fairclough; Harriet F. Peterson; Victor Chang 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

Assessment of health related quality of life has become an important endpoint in many cancer clinical trials. Because the participants of these trials often experience disease and treatment related morbidity and mortality, non-random missing assessments are inevitable. Examples are presented from se